Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeRecruitingNot stated2026-09-01NCT07570589

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Centre Hospitalier Universitaire de Nice229

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ch de Boulogne sur MerBoulogne-sur-MerFrance1
CHU Charles NicolleRouenFrance5
CHU d'AngersAngersFrance25
Chu de GrenobleGrenobleFrance5
Chu de LilleLilleFrance17
CHU de NiceNiceFrance11
Chu de ToulouseToulouseFrance20
Chu Dupuytren 1LimogesFrance1
GHICL Saint Vincent de PaulLilleFrance1
Hôpital Henri MondorCréteilFrance16
Hôpital Raymond PointcarréGarchesFrance4